Through R & D we are making our way into the future.

Sanovel, through researching and developing the most innovative ideas and adopting the most agile actions has become one of the most powerful players in the Turkish pharmaceutical industry. The principles underlying its R & D are openness to innovation, development and change, respect for the environment and society and providing human value. The firm utilises its scientific and technical infrastructure, its top quality facilities and qualified workforce to reach an ever higher standard.

Our difference lies in the difference we can make.

All the products in our portfolio have been developed as a result of our R & D efforts. Our activities are currently directed towards the production of new molecules and development of innovative products which will carry Sanovel forward into the future.

Our key principles are to convert difficulties into opportunities and to adopt an innovative style of thought. We aim to compete with the pharmaceutical sector globally across 5 continents by developing medications in virtually all possible dosage forms in our R & D centre, with its groups focusing on different therapeutic areas.

Sanovel as a company focuses in all its R & D activities on major and innovative goals. We are working with all our strength to achieve change and lasting solutions rooted in the area of health. Our aim is to innovate in a way that will bring us worldwide renown.

All our staff and facilities share the aim of carrying the Turkish Pharmaceutical Industry into the future and achieving major success in the global market.

Sanovel has its face towards the future

The Sanovel R and D Centre

All of the research carried out in our R & D centre is scientifically-focused. Our team working on the development of equivalent generic drugs leads in its field. By acquiring the highest possible level of understanding of innovation, it supports our country to develop its technological and scientific potential. The team develops innovative products within its wide portfolio to create a healthy future. The centre's fundamental principles are development, innovation and valuing human life.

Our fundamental goal is to utilise the latest technologies at the product development stage, to speedily develop key products, to bring them to market and to achieve a leading status in the sector by making a real difference. Thanks to this approach, Sanovel, by successfully undertaking its responsibilities, is making products that are usually difficult to obtain easily accessible and widely available.

Our strong team also works with full dedication to develop niche products alongside the standard products. As a result of our diligent research, we have introduced numerous new molecules and generic equivalent products to the Turkish market. Furthermore, with the experience gained in the EU, USA and Canada in particular, Sanovel has developed and continues to develop, products that will be marketed globally. All the products the firm has developed are protected by Intellectual Property law.

The productive, agile, innovative research at Sanovel is ahead of the times. This research base and our innovative outlook have made Sanovel one of the most important firms in the Turkish Pharmaceutical Industry.

We aim to carry the Turkish Pharmaceutical Industry into the future and achieve major success in the global market.

Sanovel R and D consists of the following four divisions;
  • Formulation optimisation
  • Chemical Analysis
  • Process optimisation and technology transfer
  • CMC (Chemistry, Manufacturing and Controls)
Our R & D products
  • Solids (tablets, capsules and pellets)
  • Semi-solids
  • Liquids
    Are prepared as sterile dosage forms. Our new products are developed within a wide portfolio of indications.
R & D Activities

As well as the development of conventional generic medications, the following are examples of projects where the aim is to be the first generic formulation in the global market, in particular in Turkey, the USA, Canada and Europe:

  • Combination formulations
  • Innovative solid dosage forms produced using new production technologies, such as bi- and tri-layer tablets, capsules within a capsule, pellet-based tablets etc.
  • ODT (orally disintegrating tablet) formulations

Awards we have won

At the 5th Summit of R & D Centres held on the 27th September 2016, we were awarded the first prize in Turkey in the category of competence in Intellectual Property law by the Industry and Economy Minister.

Moreover, we won the first prize in the Pharmaceutical Sector for our R & D activities.
Pharmaceutical Firm making the most patent applications. 1st Prize.

At the 6th Summit for R&D and Design Centres held on 20th-21st December 2017, we won first prize in our sector for two consecutive years.
Pharmaceutical Firm making the most patent applications. 1st Prize.

At the 8th International Medicinal Chemistry Congress amongst the awards for R & D, we won first prize in the category "Pharmaceutical Firm making the most patent applications".

Our investment in R & D

We are investing for the future

Sanovel continuously invests in development and optimisation. Ever since the foundation of the company, our doors have remained open to change, novel ideas and innovation. We aim to reach excellence in production through utilising advanced technologies and the infrastructure required at that time.

Our firm adheres to the rules enshrined within the GMP (Good Manufacturing Practice) framework by making use of high technology devices and conducting our R & D studies with the latest technology available within the pharmaceutical field. Our products are developed for regulated markets by using a QbD (Quality by Design) approach and achieve leading status when they enter the market.

Our Quality Policy

Find out about the quality policy our firm uses to manufacture products for a healthy life.

Our Quality Policy

Production to World Standards that Leads in the Sector

Sanovel, with its world standard production facilities, technological infrastructure, strong R & D basis and qualified workforce, works to produce a healthy future and is a leader in its own sector. Its aim, through innovation, agility and respect for society and the environment, is to go from strength to strength each day thanks to its knowledge of manufacturing to high standards, and to have its name associated with success in the global market.

Production